The FDA sent a warning letter this month to Novo Nordisk, alleging the drugmaker failed to report, in a timely manner, potential side effects in patients who took its popular medications containing semiglutide.
FDA sends warning letter to maker of Ozempic, Wegovy over unreported potential GLP-1 side effects
Related Posts
-
Iowans welcome National Guard unit home from deployment in Middle East
An emotional day at the Des Moines Airport as Iowans welcome soldiers home.
-
Iowa House passes bill requiring radon mitigation systems in new homes
The Iowa House approved a bill requiring radon mitigation systems in newly built homes, aiming…
-
US military refueling plane goes down in Iraq and rescue is underway
An American military refueling plane has gone down in Iraq and rescue efforts are underway.
-
Tracking World Baseball Classic quarterfinals ticket prices
Team USA had to sweat it out, but officially advanced to the next round
Leave a Reply